Page last updated: 2024-10-22

albendazole and Bronchitis, Chronic

albendazole has been researched along with Bronchitis, Chronic in 1 studies

Bronchitis, Chronic: A subcategory of CHRONIC OBSTRUCTIVE PULMONARY DISEASE. The disease is characterized by hypersecretion of mucus accompanied by a chronic (more than 3 months in 2 consecutive years) productive cough. Infectious agents are a major cause of chronic bronchitis.

Research Excerpts

ExcerptRelevanceReference
" Serological tests confirmed the diagnosis of pulmonary strongyloidiasis, and both patients were treated with anti-helminthic medications, including albendazole and ivermectin."3.72Pulmonary strongyloidiasis presenting as chronic bronchitis leading to interlobular septal fibrosis and cured by treatment. ( Carrick, J; Mukerjee, CM; Walker, JC; Woods, RL, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mukerjee, CM1
Carrick, J1
Walker, JC1
Woods, RL1

Other Studies

1 other study available for albendazole and Bronchitis, Chronic

ArticleYear
Pulmonary strongyloidiasis presenting as chronic bronchitis leading to interlobular septal fibrosis and cured by treatment.
    Respirology (Carlton, Vic.), 2003, Volume: 8, Issue:4

    Topics: Aged; Albendazole; Anthelmintics; Australia; Bronchitis, Chronic; Humans; Ivermectin; Male; Pulmonar

2003